“Your source for timely information on under-followed emerging growth companies”
Daily Notes:
4/8/2015
Top Story:
Inovio Pharmaceuticals Selected by DARPA to Lead a $45 Million Program to Expedite Development of Novel Products...
Inovio Pharmaceuticals Selected by DARPA to Lead a $45 Million Program to Expedite Development of Novel Products to Prevent and Treat Disease Caused by Ebola
Wednesday, April 8, 2015
Inovio Pharmaceuticals Selected by DARPA to Lead a $45 Million Program to Expedite Development of Novel Products to Prevent and Treat Disease Caused by Ebola
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment